Clinical Trial Update: β-alanine in the Treatment of Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating β-alanine in the treatment of advanced hepatocellular carcinoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• β-alanine (beta-alanine)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING